Joseph C. Wu
NIH Rank #250
- Program Leader
- Top 5% Funded
- R01 Holder
- Early Career
- Mentor
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 2204699Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$13.5M
Full award amounts, FY2025
Award Records
19
Records listing this PI
Award-Linked Rank
#250
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Joseph C. Wu as a PI. Multi-PI records show the full award amount for context.
- 1UG3TR005845-01UG3Assessing Effects of Microgravity on Cardiovascular Aging with AI and 3D Organoids$3.2Maward amount
- 1UG3AG097135-01UG3AI-driven Drug Discovery Targeting Cardiac Fibrosis in Aging Heart$900.2Kaward amount
- 2R01HL150693-05R01Elucidating Anthracycline-Induced Cell Type-Specific Cardiovascular Toxicity with CRISPRi/a Screens$769.5Kaward amount
- 5R01HL130020-10R01Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs$766.8Kaward amount
- 1R01HL176822-01R01Unraveling Proteasome Inhibitor-Induced Cardiovascular Toxicity through Integrative Multiomics$717.2Kaward amount
- 5R01HL171102-02R01Modeling Susceptibility to Radiation Therapy-induced Cardiotoxicity Using Cell Village iPSCs$690.1Kaward amount
- 5R01HL146690-07R01Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy$678.7Kaward amount
- 5R01HL141371-08R01Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy$676.4Kaward amount
- 5R01HL113006-13R01Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling$675.3Kaward amount
- 5R01HL141851-08R01Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs$657.1Kaward amount
+9 more grants not shown.
Award organization
Organizations that administered FY2025 awards listing Joseph C. Wu as a PI.
FY2025 award administered by Stanford University (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardStanford University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #475
- 2024Entered Top 25% NationallyRanked #475
- 2024Entered Top 10% NationallyRanked #475
- 2024Entered Top 5% NationallyRanked #475
- 2025$10M Cumulative Funding
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$25M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Joseph C. Wu.
Mark Mercola
Stanford University
15
shared awards
Wing H. Wong
Stanford University
9
shared awards
Ronglih Liao
Stanford University
7
shared awards
Adam J Chicco
Stanford University
4
shared awards
Jayakumar Rajadas
Stanford University
4
shared awards
America Facundo
Stanford University
3
shared awards
John M. Pauly
Stanford University
3
shared awards
Koen Nieman
Stanford University
3
shared awards
Mary Red-horse
Stanford University
3
shared awards
Vinicio A De Jesus Perez
Stanford University
3
shared awards